| Market Cap | ₹1,486Cr |
| ROE | 16.57% |
| P/E Ratio(TTM) | 24.42 |
| EPS(TTM) | 9.12 |
| P/B Ratio | 6.20 |
| Dividend Yield | 1.12% |
| Industry P/E | 40.62 |
| Book Value | 35.91 |
| Debt to Equity | 0.04 |
| Face Value | 2 |
| Parent Organisation | Jagsonpal Pharmaceuticals Limited. |
| Managing Director | Mr. Manish Gupta |
| NSE Symbol | JAGSNPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |